Conversely, enforced expression of miR-142-3p in HSPCs from healthy controls and AML patients down-regulates the expression of CCNT2 and TAB2 and promotes myeloid differentiation (Wang et al., 2012b). The gene discussed is CCNT2; the disease is acute myeloid leukemia.